XML 13 R3.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenues:        
Net product sales $ 37,200 $ 36,024 $ 76,103 $ 70,694
Cost of product sales 9,857 10,518 18,314 18,962
Gross profit 27,343 25,506 57,789 51,732
Operating expenses:        
Research and development 2,934 4,432 5,213 9,040
General and administrative 14,471 13,905 27,173 28,879
Sales and marketing 11,575 13,614 23,886 25,056
Total operating expenses 28,980 31,951 56,272 62,975
(Loss) income from operations (1,637) (6,445) 1,517 (11,243)
Other expense, net (744) (2,790) (1,263) (1,152)
Net (loss) income (2,381) (9,235) 254 (12,395)
Other comprehensive loss:        
Unrealized loss on short-term investments (2) (2) (14) (21)
Comprehensive (loss) income $ (2,383) $ (9,237) $ 240 $ (12,416)
Basic net (loss) income per common share $ (0.02) $ (0.06) $ 0 $ (0.08)
Diluted net (loss) income per common share $ (0.02) $ (0.06) $ 0 $ (0.08)
Weighted average common shares outstanding, basic 154,020 152,305 153,804 151,900
Weighted average common shares outstanding, diluted 154,020 152,305 197,751 151,900